Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Inner Mongolia Fudan Mengyao Biotechnology is a biopharmaceutical company based in Hohhot, Inner Mongolia, specializing in the development and production of recombinant protein vaccines. Formed through a strategic collaboration with Fudan University, the company focuses on applying advanced genetic engineering to animal health, particularly for the prevention of Foot-and-Mouth Disease (FMD). Its flagship product is a recombinant FMD vaccine that offers improved safety and efficacy compared to traditional inactivated vaccines. The company operates a large-scale, GMP-certified manufacturing facility in the Helingeer Economic Development Zone to support its industrialization goals and regional biosecurity.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Inner Mongolia Fudan Mengyao Biotechnology.